McElhenny Sheffield Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$519K Buy
433
+107
+33% +$109K 0.13% 36
2026
Q1
$300K Buy
326
+45
+16% +$45.6K 0.07% 70
2025
Q4
$302K Buy
+281
New +$269K 0.07% 73
2023
Q1
Sell
-56
Closed -$20.5K 377
2022
Q4
$20.5K Buy
+56
New +$19.9K 0.01% 263

Other funds holding LLY

McElhenny Sheffield Capital Management's LLY Position: Q2 2026 in Review

McElhenny Sheffield Capital Management increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $109K and bringing the position to 433 shares worth $519K. The position accounts for 0.13% of the portfolio, ranked #36.

McElhenny Sheffield Capital Management first reported a position in LLY in Q4 2022 and has held it in 4 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • McElhenny Sheffield Capital Management held 433 shares of Eli Lilly worth $519K as of Q2 2026.
  • McElhenny Sheffield Capital Management bought 107 Eli Lilly shares in Q2 2026, an estimated $109K.
  • Eli Lilly made up 0.13% of McElhenny Sheffield Capital Management's portfolio in Q2 2026, its #36 holding.
  • McElhenny Sheffield Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 4 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on McElhenny Sheffield Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.